Condition reference
PainSoft tissue surgery pain
Explore the linked guideline and related drug references. A matching drug entry does not establish a treatment recommendation.
WSAVA guideline
Guidelines for the Recognition, Assessment and Treatment of Pain
Soft tissue surgery beyond the reproductive protocols of T03/T04 may cause mild-to-severe postoperative pain. Preventive, multimodal analgesia with local anaesthesia "included whenever possible" is the rule; locoregional methods — incisional and specific nerve blocks (e.g. intercostal), epidural and wound catheters — are highly recommended in all cases and mandatory without controlled drugs. Where NSAIDs alone fail, alternatives (e.g. regular opioids) are added. Major soft tissue surgery (mass removal, mastectomy = moderate-to-severe) may cause chronic pain with a neuropathic component, where perioperative gabapentin has human-medicine-based potential. Box 8: feline injection-site sarcoma removal — fentanyl + ketamine CRIs + bupivacaine wound catheter.
WSAVA Pain GL 2022/2023 (JSAP doi 10.1111/jsap.13566)
Key findings
- Pain spans mild–severe; phase balance depends on pre-op pain and trauma location/magnitude; where NSAIDs fail, add alternatives e.g. regular opioid administration (§3.4, Tables 23–24).
- LA menu as printed: incisional and specific nerve blocks (e.g. intercostal), neuraxial (epidural), wound catheters — highly recommended in all cases; mandatory when opioids unavailable (§3.4).
- Perceived-pain table: mass-removal resection/reconstruction, mastectomy = moderate-to-severe; laparotomy/thoracotomy add aspiration-pneumonia risk (Table 11; §1).
- Major STS may cause chronic pain with neuropathic component; no veterinary gabapentin studies in nerve-damage surgery; human data suggest value (card; §3.4).
- Minor STS (Table 23): pre-/intra-op opioid + NSAID ± α2 ± ketamine + LA; post-op NSAID (if not pre-op) ± opioid + non-drug care.
- No-controlled tier: NSAID ± α2 + metamizole or paracetamol (not cats) ± gabapentin; injectable tramadol may replace the opioid; LA + IV lidocaine are critical (Tables 23–24).
- Major STS (Table 24): intra-op opioid/α2/ketamine/lidocaine infusions (unneeded with effective block); 24 h post-op NSAID + tapered infusions + adjuncts + wound catheters + cold therapy/acupuncture; later opioids titrated off + NSAIDs.
Drugs named in WSAVA’s own guideline text
As printed in WSAVA’s document, not this app’s own extracted data — see “Related drugs in this reference” below for that.
Methadone (Cat (Box 8))
Ketamine (Cat (Box 8))
Midazolam (Cat (Box 8))
Propofol (Cat (Box 8))
Fentanyl (Cat (Box 8))
Bupivacaine 0.5% (Cat (Box 8))
Buprenorphine (Cat (Box 8))
NSAID (approved) (Cat (Box 8))
Paracetamol (**Dog only**)
Metamizole (dipyrone) (Dog & Cat)
Gabapentin (Dog / Cat)
Recommendations
Preventive + multimodal analgesia with LA techniques whenever possible
Expert consensus (GPC, §3.4)
Incisional/specific nerve blocks (e.g. intercostal), epidural, wound catheters in all cases; mandatory without controlled drugs
Expert consensus (GPC)
If NSAIDs insufficient → add alternatives incl. regular opioids
Expert consensus (GPC)
Minor STS: opioid + NSAID ± α2 ± ketamine + LA; post-op NSAID ± opioid
Tiered protocol (Table 23)
Major STS: intra-op infusions, reduce/omit after effective block; taper 24 h + adjuncts + cold therapy/acupuncture
Tiered protocol (Table 24)
Non-controlled: NSAID ± α2 + metamizole or paracetamol (dog only) ± gabapentin; tramadol may replace opioid
Tiered protocol (Tables 23–24)
Perioperative gabapentin where major surgery risks neuropathic/chronic pain
Expert consensus, low evidence (GPC)
Same NSAID pre-/post-op; euthanasia when pain uncontrollable + poor prognosis
Expert consensus (GPC card)
Related drugs in this reference (2)
The quoted line under each drug is its own already-extracted indication text that matched this condition — the reason it’s listed, not a paraphrase. Open a drug for its full species/route breakdown, calculator, and complete adverse-effect list.
Showing 2 of 2 linked drug records. Open a record for species, route and source details.
CARPROFEN
“® OstiFenis indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tiss…”
Source dose preview: 2.2 mg/kg q12h or 4.4 mg/kg q24h, q12–24h, PO or SC (Dog)
Adverse-effect notes: GI (vomiting, anorexia, diarrhea) — Most common, usually mild (<2%) · Idiosyncratic acute hepatotoxicity — Rare (~0.05%), typically 2–3 weeks after starting
ROBENACOXIB
“maximum of 3 days. OstiRobe Injection is indicated for the control of postoperative pain and inflammation associated with soft tissue surgery in dogs ≥ 4 months…”
Source dose preview: 1–2 mg/kg, q24h, PO (Dog)
Adverse-effect notes: GI (vomiting, soft feces, diarrhea) — Most common, usually mild/self-limiting · ↑ Liver enzyme activity — With long-term oral use (not always associated with pathology)
From the Soft-tissue-Surgery card + 02-pain-2022.md + EN part03 §3.4 (Tables 23–24; Box 8 verbatim). Scoped to general soft-tissue principles + non-reproductive examples (mass removal, mastectomy, intercostal block, injection-site sarcoma); castration/OVH in T03/T04. Dog/class-only entries dosed from Tables 12–16; no [verify] flags outstanding.